Logo-jcvtr

J Cardiovasc Thorac Res. 2022;14(4): 214-219. doi: 10.34172/jcvtr.2022.30549
PMID: 36699552        PMCID: PMC9871161

Original Article

Predictive value of C-reactive protein/albumin ratio for no-reflow in patients with non-ST-elevation myocardial infarction

Aydın Rodi Tosu 1 ORCID, Tufan Çinar 2 * ORCID, Muhsin Kalyoncuoğlu 1, Halil İbrahim Biter 1, Sinem Çakal 1, Beytullah Çakal 3, Murat Selçuk 2, Erdal Belen 1, Mehmet Mustafa Can 1

Cited by CrossRef: 0

1- Aydemir S, Aydın S, Altınkaya O, Aksakal E, Özmen M. Evaluation of Hematological and Biochemical Parameters that Predict the No-reflow Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention. Angiology. 2025;76(10):999 [Crossref]
2- Kalyoncuoglu M, Gumusdag A, Oguz H, Ogur H, Ozturk S, Karabulut D. Newly defined biomarker for the no reflow phenomenon in patients with non-ST elevation acute coronary syndrome; uric acid to creatinine ratio. Acta Cardiologica. 2025;80(1):61 [Crossref]
3- Krasniqi X, Spanca A, Gojani G, Vincelj J, Berisha B, Bakalli A. Inflammation-Based C-Reactive Protein-to-Albumin Ratio for No-Reflow Prediction in STEMI. Biomedicines. 2026;14(6):1383 [Crossref]
4- Kurniawan R, Oktafia P, Saputra P, Purwati D, Saputra M, Maghfirah I, Faizah N, Oktaviono Y, Alkaff F. The roles of C-reactive protein-albumin ratio as a novel prognostic biomarker in heart failure patients: A systematic review. Current Problems in Cardiology. 2024;49(5):102475 [Crossref]